Journal of Pharmacovigilance

Editorial

New Theoretical Background for Tuberculosis Treatment

• Jagadevappa S Patil

Editorial

Generic Pharmaceuticals: Is Pharmacovigilance Required?

• Suprita A Tawde

Research Article

Serious Adverse Events Reporting and Follow-Up Requirements in the European and Developing Countries Clinical Trials Partnership-Funded Clinical Trials: Current Practice

• Jean Marie Vianney Habarugira, Antonia Agustí and Michael Makanga

Short Communication

Assessment of Endogenous Biochemical Composites Emphasizing Drug Interaction of Cardiovascular Combined Dosage Formulation in Marketed Product

• Rakesh Das and Tapan Kumar Pal

Research Article

The Role of Multidrug Interactions in the Safety of Pharmacotherapy for Concomitant Parkinson’s Disease and Arterial Hypertension in Poland

• Anna Bitner, Pawel Zalewski, Julia L Newton and Jacek J Klawe

Case Report

Ertapenem-induced Neuropsychiatric Symptoms in an Elderly Patient with Chronic Kidney Disease Resulting to a Prescribing Cascade

• Ferdinand Z Ribo and Annabelle A Ribo

Mini Review

RNAi-based Cancer Therapeutics: Are we there yet?

• Vaibhav Saxena

Research Article

Life Threatening Acute Heart Failure in Two Young Adults Treated with Antidepressant Medication

• Inga Jóna Ingimarsdóttir and Gerhard Wikström